{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:57:21Z","timestamp":1788404241026,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.gastro.2025.09.010","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:11:00Z","timestamp":1768900260000},"page":"595-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial"],"prefix":"10.1053","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-5950","authenticated-orcid":false,"given":"Grishma","family":"Hirode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman F.","family":"Zangneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Cerocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korosh","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lima A.","family":"El-Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Winick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2640-2211","authenticated-orcid":false,"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.09.010_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2025.09.010_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.09.010_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.09.010_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib6","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2025.09.010_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"10.1053\/j.gastro.2025.09.010_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.gastro.2025.09.010_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cgh.2010.08.019","article-title":"Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma","volume":"9","author":"Yang","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2025.09.010_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Singal","year":"2014","journal-title":"PLoS Med"},{"key":"10.1053\/j.gastro.2025.09.010_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for hepatocellular carcinoma: current best practice and future direction","volume":"157","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.09.010_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2025.09.010_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.09.010_bib16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.09.010_bib17","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/hep4.2045","article-title":"Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: results of a network meta-analysis","volume":"6","author":"Singal","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2025.09.010_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23504","article-title":"Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort","volume":"5","author":"Parikh","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.gastro.2025.09.010_bib19","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170436","article-title":"Hepatocellular carcinoma surveillance with ultrasound-cost-effectiveness, high-risk populations, uptake","volume":"91","author":"Ronot","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1053\/j.gastro.2025.09.010_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2046-4053-2-37","article-title":"Diagnostic performance of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol","volume":"2","author":"Huang","year":"2013","journal-title":"Syst Rev"},{"key":"10.1053\/j.gastro.2025.09.010_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2025.09.010_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.09.010_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1055-9965.EPI-18-0281","article-title":"GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of Galadus score","volume":"28","author":"Yang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2025.09.010_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2024.09.008","article-title":"A phase 3 biomarker validation of GALAD for the detection of hepatocellular carcinoma in cirrhosis","volume":"168","author":"Marsh","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.09.010_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1373\/clinchem.2019.308965","article-title":"A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B","volume":"65","author":"Yang","year":"2019","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2025.09.010_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/HEP.0000000000000953","article-title":"HES V2.0 outperforms GALAD for detection of HCC: a phase 3 biomarker study in the United States","volume":"81","author":"El-Serag","year":"2025","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.09.010_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.09.010_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2015.12.042","article-title":"Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients","volume":"14","author":"Berhane","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.09.010_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"Delong","year":"1988","journal-title":"Biometrics"},{"key":"10.1053\/j.gastro.2025.09.010_bib32","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"388","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2025.09.010_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2014.08.008","article-title":"Surveillance for hepatocellular carcinoma","volume":"28","author":"Sherman","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.09.010_bib34","first-page":"5419","article-title":"A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma","volume":"53","author":"Taketa","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2025.09.010_bib35","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","article-title":"Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein","volume":"328","author":"Sato","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.09.010_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840220317","article-title":"A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients","volume":"22","author":"Shiraki","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.09.010_bib37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1046\/j.1440-1746.2001.02643.x","article-title":"Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive \u03b1-fetoprotein","volume":"16","author":"Oka","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm12030949","article-title":"The performance of GALAD Score for diagnosing hepatocellular carcinoma in patients with chronic liver diseases: a systematic review and meta-analysis","volume":"12","author":"Guan","year":"2023","journal-title":"J Clin Med"},{"key":"10.1053\/j.gastro.2025.09.010_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1756283X10385964","article-title":"Surveillance for hepatocellular carcinoma: in whom and how?","volume":"4","author":"El-Serag","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2025.09.010_bib40","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/COC.0000000000000388","article-title":"Obesity is independently associated with increased risk of hepatocellular cancer-related mortality: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.gastro.2025.09.010_bib41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.ijo.0803020","article-title":"Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study","volume":"29","author":"Batty","year":"2005","journal-title":"Int J Obes"},{"key":"10.1053\/j.gastro.2025.09.010_bib42","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2021.06.012","article-title":"Dynamic changes in ultrasound quality for hepatocellular carcinoma screening in patients with cirrhosis","volume":"20","author":"Schoenberger","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3350\/cmh.2019.1001","article-title":"Hepatocellular carcinoma surveillance in the 21st century: saving lives or causing harm?","volume":"25","author":"Hanouneh","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"10.1053\/j.gastro.2025.09.010_bib44","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00357-019-09345-1","article-title":"ROC and AUC with a binary predictor: a potentially misleading metric","volume":"37","author":"Muschelli","year":"2020","journal-title":"J Classif"},{"key":"10.1053\/j.gastro.2025.09.010_bib45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11606-011-1952-x","article-title":"Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review","volume":"27","author":"Singal","year":"2012","journal-title":"J Gen Intern Med"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525059931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525059931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:25:03Z","timestamp":1780201503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525059931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0016508525059931"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.09.010","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}